Am
J Med Sci 2000 Aug;320(2):124-7.
Estrogen replacement therapy is underutilized among postmenopausal women
at high risk for coronary heart disease.
Massey CV, Hupp CH, Kreisberg M, Alpert MA, Hoff C.
Department of Internal Medicine, University of South Alabama College
of Medicine, Mobile 36617, USA.
Observational studies have found that estrogen replacement therapy (ERT)
reduces the risk of coronary heart disease (CHD) in postmenopausal women.
To determine the frequency of current use of ERT in an economically and
racially diverse group of women at high risk for CHD, we examined the
medical records of 393 women older than 40 who were admitted to the University
of South Alabama Medical Center with symptoms suggestive of angina. Women
in the study group were classified as African American or European American
and data were examined for significant differences. Use of ERT was lower
in African American women (11 of 111, 9.9%) than in European American
women (26 of 152, 17.1%, odds ratio 1.9). Compared with the reported utilization
of ERT in middle-class European American women, ERT is underutilized in
this economically diverse group of women at high risk for coronary heart
disease. In our population, European American women were twice as likely
to be receiving ERT as African American women.
PMID: 10981488 [PubMed - indexed for MEDLINE]